Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Matthew G JohnsonJulie M StrizkiMichelle L BrownHong WanHala H ShamsuddinMoti RamgopalDiana F FlorescuPierre DelobelIlsiyar M KhaertynovaJosé F FloresLeon F FoucheShan-Chwen ChangAngela Williams-DiazJiejun DuJay A GroblerAmanda PaschkeCarisa De AndaPublished in: Infection (2023)
NCT04575597.